GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (FRA:18H) » Definitions » Price-to-Free-Cash-Flow

PreveCeutical Medical (FRA:18H) Price-to-Free-Cash-Flow : N/A (As of May. 24, 2025)


View and export this data going back to 2017. Start your Free Trial

What is PreveCeutical Medical Price-to-Free-Cash-Flow?

As of today (2025-05-24), PreveCeutical Medical's share price is €0.017. PreveCeutical Medical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Hence, PreveCeutical Medical's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for PreveCeutical Medical's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:18H's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.2
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

PreveCeutical Medical's Free Cash Flow per Share for the three months ended in Dec. 2024 was €0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.00.

During the past 10 years, PreveCeutical Medical's highest 3-Year average Free Cash Flow per Share Growth Rate was 65.30% per year. The lowest was -81.70% per year. And the median was 15.70% per year.


PreveCeutical Medical Price-to-Free-Cash-Flow Historical Data

The historical data trend for PreveCeutical Medical's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical Price-to-Free-Cash-Flow Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PreveCeutical Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PreveCeutical Medical's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, PreveCeutical Medical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's Price-to-Free-Cash-Flow falls into.


;
;

PreveCeutical Medical Price-to-Free-Cash-Flow Calculation

PreveCeutical Medical's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.017/0
=N/A

PreveCeutical Medical's Share Price of today is €0.017.
PreveCeutical Medical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

PreveCeutical Medical  (FRA:18H) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


PreveCeutical Medical Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical Business Description

Traded in Other Exchanges
Address
5428 Marine Drive, Suite 2500, Vancouver, BC, CAN, V7W 2R2
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical Headlines

No Headlines